Why the study?
Sex differences in doxorubicin-induced systemic inflammation and the potential effects on hepatic cytochrome P450 expression had not been determined.
Population
Male and female C57Bl/6 mice
Comparison
DOX (20 mg/kg by intraperitoneal injection) evaluated across sexes
Design
Preclinical animal study
Follow-up
24 and 72 h
Authors
Loading...
May support sex-specific DOX monitoring in cardio-oncology; leaves open prospective validation of CYP effects.
Sex differences in doxorubicin-induced systemic inflammation and hepatic CYP inhibition may contribute to sexually dimorphic drug interactions and organ toxicity.
Grant et al. (2020) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: